Characterization of antigen-presenting properties of tumour cells using virus-specific cytotoxic T lymphocytes

British Journal of Cancer

Volumn 82, Issue 8, 2000, Pages 1474-1479

  Spierings, D C J ^a   Agsteribbe, E ^a   Wilschut, J ^a   Huckriede, A ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Antigen presentation; Immunotherapy; Influenza virus; Tumour

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; IMMUNOFLUORESCENCE TEST; INFLUENZA VIRUS; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL;

ANIMALS; ANTIGEN-PRESENTING CELLS; FEMALE; GENES, MHC CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INFLUENZA A VIRUS; INTERFERON-GAMMA, RECOMBINANT; L CELLS (CELL LINE); MICE; MICE, INBRED A; NEUROBLASTOMA; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0034123993     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.1135     Document Type: Article

References (31)

1. Bernards R, Dessain SK and Weinberg RA (1986) N-myc amplification causes down-modulation of MHC class I antigen expression in neuroblastoma. Cell 47: 667-674
2. Christinck ER, Luscher MA, Barber BH and Williams DB (1991) Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis. Nature 352: 67-70
3. Darrow TL, Slingluff CL Jr and Seigler HF (1989) The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumour antigens. J Immunol 142: 3329-3335
4. Demotz S, Grey HM and Sette A (1990) The minimal number of class II MHC-antigen complexes needed for T cell activation. Science 249: 1028-1030
5. Ferrone S and Marincola FM (1995) Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol Today 16: 487-494
6. Froelich CJ, Orth K, Turbov J, Seth P, Gottlieb R, Babior B, Shah GM, Bleackley RC, Dixit VM and Hanna W (1996) New paradigm for lymphocyte granule-mediated cytotoxicity. Target cells bind and internalize granzyme B, but an endosomolytic agent is necessary for cytosolic delivery and subsequent apoptosis. J Biol Chem 271: 29073-29079
7. Garrido F, Cabrera T, Concha A, Glew S, Ruiz-Cabello F and Stern PL (1993) Natural history of HLA expression during tumour development. Immunol Today 14: 491-499
8. Halloran PF, Urmson J, van der Meide PH and Autenried P (1989) Regulation of MHC expression in vivo. IL IFN-alpha/beta inducers and recombinant IFN-alpha modulate MHC antigen expression in mouse tissues. J Immunol 142: 4241-4247
9. Harding CV and Unanue ER (1990) Quantitation of antigen-presenting cell MHCII/peptide complexes necessary for T-cell stimulation. Nature 346: 574-576
10. Hicklin DJ, Marincola FM and Ferrone S (1999) HLA class I antigen downregulation in human cancers: T cell immunotherapy revives an old story. Mol Med Today 5: 178-186
11. Katsanis E, Xu Z, Bausero MA, Dancisak BB, Gorden KB, Davis G, Gray GS, Orchard PJ and Blazar BR (1995) B7-I expression decreases tumorigenicity and induces partial systemic immunity to murine neuroblastoma deficient in major histocompatibility complex and costimulatory molecules. Cancer Gene Ther 2: 39-46
12. Khanna R (1998) Tumour surveillance: missing peptides and MHC molecules. Immunol Cell Biol 76: 20-26
13. Klenk HD, Rott R, Orlich M and Blodorn J (1975) Activation of influenza A viruses by trypsin treatment. Virology 68: 426-439
14. 2-microaglobulin on human neuroblastoma cell lines. J Immunol 130: 2471-2478
15. Lazarowitz SG and Choppin PW (1975) Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide. Virology 68: 440-454
16. Lenardo M, Rustgi AK, Schievella AR and Bernards R (1989) Suppression of MHC class I gene by N-myc through enhancer inactivation. EMBO J 8: 3351-3355
17. Main EK, Lampson LA, Hart MK, Kornbluth J and Wilson DB (1985) Human neuroblastoma cell lines are susceptible to lysis by natural killer cells but not by cytotoxic T lymphocytes. J Immunol 135: 242-246
18. Marincola FM, Shamamian P, Simonis TB, Abati A, Hackett J, O'Dea T, Fetsch P, Yannelli J, Restifo NP, Mulé JJ and Rosenberg SA (1994a) Locus-specific analysis of human leukocyte antigen class I expression in melanoma cell lines. J Immunother Emphasis Tumour Immunol 16: 13-23
19. Marincola FM, Shamamian P, Alexander RB, Gnarra JR, Turetskaya RL, Nedospasov SA, Simonis TB, Taubenberger JK, Yannelli J, Mixon A, Restifo NP, Herlyn M and Rosenberg SA (1994b) Loss of HLA haplotype and B locus down-regulation in melanoma cell lines. J Immunol 153: 1225-1237
20. Nagata S (1997) Apoptosis by death factor. Cell 88: 355-365
21. Parker CE and Gould KG (1996) Influenza A virus - a model for viral antigen presentation to cytotoxic T lymphocytes. Semin Virol 7: 61-73
22. Restifo NP, Esquivel F, Kawakami Y, Yewdell JW, Mulé JJ, Rosenberg SA and Bennink JR (1993) Identification of human cancers deficient in antigen processing. J Exp Med 177: 265-272
23. Rivoltini L, Barracchini KC, Viggiano V, Kawakami Y, Smith A, Mixon A, Restifo NP, Topalian SL, Simonis TB, Rosenberg SA and Marincola FM (1995) Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes. Cancer Res 55: 3149-3157
24. Seliger B, Maeurer MJ and Ferrone S (1997) TAP off - tumors on. Immunol Today 18: 292-299
25. Strand S and Galle PR (1998) Immune evasion by tumours: involvement of the CD95 (APO-1/Fas) system and its clinical implications. Mol Med Today 4: 63-68
26. Sykulev Y, Joo M, Vturina I, Tsomides TJ and Eisen HN (1996) Evidence that a single peptide - MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 4: 565-571
27. Townsend ARM, McMichael AJ, Carter NP, Huddlesoton JA and Brownlee GG (1984) Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells. Cell 39: 13-25
28. Van't Veer LJ, Beijersbergen RL and Bernards R (1993) N-myc suppresses major histocompatibility complex class I gene expression through down-regulation of the p50 subunit of NF-κB. EMBO J 12: 195-200
29. Yewdell JW, Bennink JR, Smith GL and Moss B (1985) Influenza A virus nucleoprotein is a major target antigen for cross reactive anti-influenza A virus cytotoxic T lymphocytes. Proc Natl Acad Sci USA 82: 1785-1789
30. Ziegler MM, Ishizu H, Nagabuchi E, Takada N and Arya G (1997) A comparative review of the immunobiology of murine neuroblastoma and human neuroblastoma. Cancer 79: 1757-1766
31. Zier KS, Pierson GR and Brown V (1990) Susceptibility of human neuroblastoma cell lines to cytotoxic T lymphocyte-mediated lysis. J Neuroimmunol 28: 153-160